Literature DB >> 8134838

High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR.

P J Lodi1, D S Garrett, J Kuszewski, M L Tsang, J A Weatherbee, W J Leonard, A M Gronenborn, G M Clore.   

Abstract

The three-dimensional structure of a member of the beta subfamily of chemokines, human macrophage inflammatory protein-1 beta (hMIP-1 beta), has been determined with the use of solution multidimensional heteronuclear magnetic resonance spectroscopy. Human MIP-1 beta is a symmetric homodimer with a relative molecular mass of approximately 16 kilodaltons. The structure of the hMIP-1 beta monomer is similar to that of the related alpha chemokine interleukin-8 (IL-8). However, the quaternary structures of the two proteins are entirely distinct, and the dimer interface is formed by a completely different set of residues. Whereas the IL-8 dimer is globular, the hMIP-1 beta dimer is elongated and cylindrical. This provides a rational explanation for the absence of cross-binding and reactivity between the alpha and beta chemokine subfamilies. Calculation of the solvation free energies of dimerization suggests that the formation and stabilization of the two different types of dimers arise from the burial of hydrophobic residues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8134838     DOI: 10.1126/science.8134838

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  62 in total

1.  Completeness of NOEs in protein structure: a statistical analysis of NMR.

Authors:  J F Doreleijers; M L Raves; T Rullmann; R Kaptein
Journal:  J Biomol NMR       Date:  1999-06       Impact factor: 2.835

2.  Solution structure of the MEF2A-DNA complex: structural basis for the modulation of DNA bending and specificity by MADS-box transcription factors.

Authors:  K Huang; J M Louis; L Donaldson; F L Lim; A D Sharrocks; G M Clore
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

3.  Breaking symmetry in the structure determination of (large) symmetric protein dimers.

Authors:  Vadim Gaponenko; Amanda S Altieri; Jess Li; R Andrew Byrd
Journal:  J Biomol NMR       Date:  2002-10       Impact factor: 2.835

Review 4.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

5.  The solution structure of the anti-HIV chemokine vMIP-II.

Authors:  A C Liwang; Z X Wang; Y Sun; S C Peiper; P J Liwang
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 6.  Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.

Authors:  Lavanya Rajagopalan; Krishna Rajarathnam
Journal:  Biosci Rep       Date:  2006-10       Impact factor: 3.840

Review 7.  Rational design of novel HIV-1 entry inhibitors by RANTES engineering.

Authors:  Luca Vangelista; Massimiliano Secchi; Paolo Lusso
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

8.  Monomeric solution structure of the prototypical 'C' chemokine lymphotactin.

Authors:  E S Kuloglu; D R McCaslin; M Kitabwalla; C D Pauza; J L Markley; B F Volkman
Journal:  Biochemistry       Date:  2001-10-23       Impact factor: 3.162

9.  Analysis of hydrophobicity in the alpha and beta chemokine families and its relevance to dimerization.

Authors:  D G Covell; G W Smythers; A M Gronenborn; G M Clore
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

10.  Polymorphism of the Duffy erythrocyte chemokine receptor in Italian patients with Behçet's disease.

Authors:  V Pittoni; S Vaglio; L Magrini; M Accorinti; P Pivetti-Pezzi; G Girelli; G Valesini
Journal:  Rheumatol Int       Date:  2003-01-18       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.